Fonte: Drug Delivery and Translational Research. Unidades: FCF, FM, IMT
Assuntos: LEISHMANIA, NANOPARTÍCULAS
ABNT
SOUZA, Regina Maia de et al. Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis. Drug Delivery and Translational Research, v. 10, p. 403–412, 2020Tradução . . Disponível em: https://doi.org/10.1007/s13346-019-00677-4. Acesso em: 01 nov. 2024.APA
Souza, R. M. de, Maranhão, R. C., Tavares, E. R., Monteiro, F. B. F., Nicodemo, A. C., Morikawa, A. T., et al. (2020). Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis. Drug Delivery and Translational Research, 10, 403–412. doi:10.1007/s13346-019-00677-4NLM
Souza RM de, Maranhão RC, Tavares ER, Monteiro FBF, Nicodemo AC, Morikawa AT, Kanashiro EHY, Amato VS. Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis [Internet]. Drug Delivery and Translational Research. 2020 ; 10 403–412.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s13346-019-00677-4Vancouver
Souza RM de, Maranhão RC, Tavares ER, Monteiro FBF, Nicodemo AC, Morikawa AT, Kanashiro EHY, Amato VS. Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis [Internet]. Drug Delivery and Translational Research. 2020 ; 10 403–412.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s13346-019-00677-4